Dr RR Baliga's "Got Knowledge Doc" Podkast

🫀 Cardiac CT Calcium Score: Key Insights 🔬📊

🔍 What is CAC?

✅ Measures calcified plaque in coronary arteries via cardiac CT 📸

✅ Higher CAC = Higher cardiovascular risk ⚠️

✅ Agatston Score: 0 (None) → >400 (Severe Atherosclerosis)

📊 Clinical Impact:

✅ Strong predictor of ASCVD events (MI, stroke, CHD death) 📉

✅ MESA Study: CAC >300 → 10-year CHD risk: 13-25%

✅ CAC = 0 → Low risk, even for some statin-eligible patients 🚀

🎯 Guidelines & Utility:

📢 Used for risk stratification in intermediate-risk patients (7.5%-20% ASCVD risk)

💊 Guides statin therapy decisions (CAC >100 = Strong statin recommendation)

⚖️ Not useful for symptomatic patients needing revascularization

🔬 Takeaway: CAC scoring enhances risk prediction, supports precision medicine, and helps optimize cardiovascular prevention strategies! 🚀

Tirzepatide & Weight Maintenance 💊📉

A phase 3 clinical trial (SURMOUNT-4) showed that continued use of tirzepatide helps maintain weight loss in adults with obesity.

Participants on tirzepatide lost an extra 5.5%, while those on placebo regained 14%.

✅ 89.5% maintained at least 80% of their weight loss, compared to 16.6% on placebo.

Common side effects were mild gastrointestinal issues 🤢.

Stopping treatment led to significant weight regain, reinforcing the need for long-term therapy. 🔬

🫀 CAUGHT-CAD Trial Summary 🔬

🔍 Objective: Investigated whether CAC scoring combined with a prevention strategy slows plaque progression in intermediate-risk patients with a family history of CAD.

📊 Key Findings:

✅ LDL Reduction: -51 mg/dL (CAC group) vs. -2 mg/dL (Usual Care) 📉

✅ Slower Plaque Progression: +15.4 mm³ vs. +24.9 mm³ (p=0.009) 🏥

✅ Less Noncalcified Plaque Growth: +5.6 mm³ vs. +15.7 mm³ (p=0.002) 🔬

✅ Regression in High-Risk Plaque (Fibrofatty/Necrotic Core): -0.8 mm³ vs. +4.5 mm³ (p=0.02) 🚀

🎯 Clinical Impact: CAC-informed strategies enhance risk stratification, reduce plaque burden, and support early statin therapy for CAD prevention. 🔄💊

🩸 Bleeding & Cancer Risk in AF Patients on Anticoagulants 🏥

🔎 Study Goal: Investigate the link between bleeding after anticoagulation for atrial fibrillation (AF) and new cancer diagnoses.

📊 Findings:

✅ Bleeding 4X increases the risk of cancer diagnosis (HR: 4.0).

🔴 GI Bleeding → 15.4X risk of GI Cancer

🟠 GU Bleeding → 11.8X risk of GU Cancer

🟡 Respiratory Bleeding → 10.1X risk of Lung Cancer

⏳ Median time to cancer diagnosis: 45 days.

🚑 Earlier-stage cancers detected after bleeding (Stage 4: 27.6% vs. 31.3%).

💡 Clinical Takeaways:

🛑 Don't ignore bleeding! It may indicate occult cancer.

🔬 Prioritize timely investigations (e.g., endoscopy, cystoscopy).

📑 Guidelines needed for cancer screening after bleeding in anticoagulated patients.

The RENOVE trial compared reduced-dose versus full-dose DOACs for extended venous thromboembolism VTE treatment in high-risk patients.

While the reduced dose cut major bleeding risk by 39% 🚨, it did not meet non-inferiority criteria for preventing VTE recurrence 🔄.

Laozi, a legendary Chinese philosopher and author of the Tao Te Ching, is regarded as the founder of Taoism.

His teachings emphasize living in harmony with the Tao (the Way), advocating simplicity, humility, and wu wei (effortless action) for a balanced life.

This study explores how environmental exposures (exposome) 🌍 and genetics 🧬 contribute to aging ⏳ and mortality ⚰️.

Using UK Biobank data 📊, researchers found that the exposome explains 17% of mortality risk, while genetics accounts for only 2%.

Smoking 🚬, socioeconomic status 💰, and physical activity 🏃‍♂️ are major environmental influences, whereas genetics plays a stronger role in dementia 🧠 and cancers 🦠.

The findings highlight the need for public health policies 🏥 targeting modifiable lifestyle factors over genetic interventions.

🩺 Lithocholic Acid (LCA) – A Caloric Restriction Mimetic for Clinical Use 💊

✅ Mimics caloric restriction by activating AMPK – key for metabolism & longevity.

✅ Enhances muscle strength & regeneration 🏋️ – potential for frailty & sarcopenia treatment.

✅ Improves insulin sensitivity & lipid metabolism 🔥 – aiding in diabetes & metabolic syndrome.

✅ Reduces inflammation & supports cardiovascular health ❤️ – protective against aging-related diseases.

🚀 Future Potential: LCA could be a novel therapeutic strategy in geriatrics & metabolic medicine.

📌 Summary of Findings

🔬 Studies: Three large cohort studies explored the impact of flavonoid-rich foods on aging and mental health in women.

✅ Key Findings:

• 🍊 Higher citrus and flavonoid intake linked to lower depression risk, especially in older women.

• 💪 Flavonoid-rich diets associated with better physical function and reduced frailty.

• 🦠 Increased F. prausnitzii (gut microbiome) with citrus intake may enhance serotonin & dopamine pathways.

📝 Conclusion: Eating flavonoid-rich foods like citrus, berries, tea, and red wine may support healthy aging and mental well-being in women.

🩺 2025 ACS Management Guidelines Summary 💊

• 🩸 DAPT recommended: Ticagrelor or prasugrel preferred over clopidogrel in PCI patients.

• 🎯 Lipid management: High-intensity statins + ezetimibe; PCSK9 inhibitors if LDL-C ≥70 mg/dL.

• 🔬 Invasive approach: Recommended for intermediate/high-risk NSTE-ACS; radial access preferred for PCI.

• 🚑 Revascularization: Complete revascularization advised for STEMI/NSTE-ACS; intracoronary imaging for complex lesions.

• ❤️ Cardiogenic shock: Emergency PCI for culprit vessel; microaxial flow pump may help select patients.

• 🏥 Secondary prevention: Lipid monitoring, cardiac rehab, and long-term risk reduction strategies are key.